MarginsXMarginsX
Home › Markets › Health Care › LMRI

Lumexa Imaging Holdings Inc. (LMRI)

LMRI trades on Nasdaq in Health Care, Medical Specialities. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$14.79
-0.14% on the day
Market cap
$1.4B
Small cap
Revenue
New registrant: no annual report filed under this company yet
Net income
New registrant: no annual report filed under this company yet

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026.

Profile

FieldValue
TickerLMRI on Nasdaq
SectorHealth Care
IndustryMedical Specialities
CountryUnited States
IPO year2025
SEC CIK0002071288
SEC industry codeServices-Medical Laboratories
Incorporated inDE

Financials

New registrant: no annual report filed under this company yet.

Warning signs

Cash runway
Cash-flow positive
$90.0M cash at September 30, 2026
Share count, 1 year
No year-earlier count
Going-concern doubt
No
10-Q filed November 12, 2026
Insider net buying, 12 months
$477K
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.10-Q 2026-11-12
Cash and burn$90.0M cash; operating cash flow $20.6M a quarter.Report 2026-09-30
Shares outstanding96,122,987 (2026-11-10).Cover page 2026-11-10
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 0 424B5 takedownsNone on EDGAR
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorPricewaterhouseCoopers LLP, Raleigh, North Carolina, United StatesPCAOB Form AP 2026-04-17
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $477K, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q3 2026
2026-09-30
$272.0M$7.2M$34.8M$90.0M$839.4MNeeds four quarters10-Q 2026-11-12
Q2 2026
2026-06-30
$264.2M$2.7M$32.8M$69.7M$835.4MNeeds four quarters10-Q 2026-08-13
Q1 2026
2026-03-31
$252.5M$1.7M$2.9M$51.2M$832.1MNeeds four quarters10-Q 2026-05-12
Q3 2026
2025-09-30
$258.9M-$3.5M$11.9M$191KNo debt tagsNeeds four quarters10-Q 2026-11-12
Q2 2026
2025-06-30
$251.4M-$7.2M$2.1M$4.7MNo debt tagsNeeds four quarters10-Q 2026-08-13
Q1 2026
2025-03-31
$245.0M-$7.7M-$14.0M$7.3MNo debt tagsNeeds four quarters10-Q 2026-05-12

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B42025-12-12
Latest annual report10-K2026-03-30
Latest quarterly / interim10-Q2026-11-12
Latest current report8-K2026-11-10
Latest proxyDEFA14A2026-04-28

Source: SEC EDGAR submissions feed, 73 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week+10.3%
1 month+39.6%
3 months+21.4%
Year to date-19.9%
1 yearNot enough price history
From 52-week high-20.1%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Medical Specialities

TickerCompanyPriceDayMarket cap
ALHCAlignment Healthcare Inc.$7.47+1.49%$1.6B
TRUPTrupanion Inc.$36.16+4.87%$1.6B
PSNLPersonalis Inc.$14.80-5.79%$1.6B
FRNMFreenome Inc.$10.09-3.07%$1.1B
FTREFortrea Holdings Inc.$19.79-2.03%$1.9B
VCYTVeracyte Inc.$24.01-1.32%$1.9B
CSTLCastle Biosciences Inc.$32.75-3.08%$1.0B
CLOVClover Health Investments Corp.$4.95-0.20%$2.7B

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier